Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-10-07 20:41:55 UTC |
---|
NP-MRD ID | NP0000980 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Chenodeoxycholic acid |
---|
Description | Chenodeoxycholic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.G., Membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487 , 16037564 , 12576301 , 11907135 ). Usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones. |
---|
Structure | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1 |
---|
Synonyms | Value | Source |
---|
3alpha,7alpha-Dihydroxy-5beta-cholanic acid | ChEBI | 7alpha-Hydroxylithocholic acid | ChEBI | Anthropodeoxycholic acid | ChEBI | Anthropodesoxycholic acid | ChEBI | CDCA | ChEBI | Chenic acid | ChEBI | Chenix | ChEBI | Chenodiol | ChEBI | Gallodesoxycholic acid | ChEBI | 3a,7a-Dihydroxy-5b-cholanate | Generator | 3a,7a-Dihydroxy-5b-cholanic acid | Generator | 3alpha,7alpha-Dihydroxy-5beta-cholanate | Generator | 3Α,7α-dihydroxy-5β-cholanate | Generator | 3Α,7α-dihydroxy-5β-cholanic acid | Generator | 7a-Hydroxylithocholate | Generator | 7a-Hydroxylithocholic acid | Generator | 7alpha-Hydroxylithocholate | Generator | 7Α-hydroxylithocholate | Generator | 7Α-hydroxylithocholic acid | Generator | Anthropodeoxycholate | Generator | Anthropodesoxycholate | Generator | Chenate | Generator | Gallodesoxycholate | Generator | Chenodeoxycholate | Generator | (+)-Chenodeoxycholate | HMDB | (+)-Chenodeoxycholic acid | HMDB | (3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oate | HMDB | (3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oic acid | HMDB | 3a,7a-Dihydroxy-5b,14a,17b-cholanate | HMDB | 3a,7a-Dihydroxy-5b,14a,17b-cholanic acid | HMDB | 3a,7a-Dihydroxy-5b-cholan-24-Oate | HMDB | 3a,7a-Dihydroxy-5b-cholan-24-Oic acid | HMDB | 7a-Hydroxy-desoxycholsaeure | HMDB | Chenodesoxycholsaeure | HMDB | Acid, chenique | HMDB | Chenofalk | HMDB | Chenophalk | HMDB | Acid, chenodeoxycholic | HMDB | Chenodeoxycholate, sodium | HMDB | Quenocol | HMDB | Solvay brand OF chenodeoxycholic acid | HMDB | Antigen brand OF chenodeoxycholic acid | HMDB | Falk brand OF chenodeoxycholic acid | HMDB | Quenobilan | HMDB | Sodium chenodeoxycholate | HMDB | Tramedico brand OF chenodeoxycholic acid | HMDB | Zambon brand OF chenodeoxycholic acid | HMDB | Acid, chenic | HMDB | Acid, gallodesoxycholic | HMDB | Chenique acid | HMDB | Estedi brand OF chenodeoxycholic acid | HMDB | Henohol | HMDB |
|
---|
Chemical Formula | C24H40O4 |
---|
Average Mass | 392.5720 Da |
---|
Monoisotopic Mass | 392.29266 Da |
---|
IUPAC Name | (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid |
---|
Traditional Name | (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid |
---|
CAS Registry Number | 474-25-9 |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O |
---|
InChI Identifier | InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16-,17-,18+,19+,20-,22+,23+,24-/m1/s1 |
---|
InChI Key | RUDATBOHQWOJDD-BSWAIDMHSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dihydroxy bile acids, alcohols and derivatives. Dihydroxy bile acids, alcohols and derivatives are compounds containing or derived from a bile acid or alcohol, and which bears exactly two carboxylic acid groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Bile acids, alcohols and derivatives |
---|
Direct Parent | Dihydroxy bile acids, alcohols and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Dihydroxy bile acid, alcohol, or derivatives
- 3-hydroxysteroid
- Hydroxysteroid
- 3-alpha-hydroxysteroid
- 7-hydroxysteroid
- Cyclic alcohol
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 165 - 167 °C | Not Available | Boiling Point | 547.15 °C. @ 760.00 mm Hg (est) | The Good Scents Company Information System | Water Solubility | 0.09 mg/mL | Not Available | LogP | 4.15 | Sangster, J. (1993). LOGKOW- a Databank of Evaluated Octanol-Water Partition Coefficients. Sangster Research Laboratories, Montreal. |
|
---|
Predicted Properties | |
---|
General References | - Tadano T, Kanoh M, Matsumoto M, Sakamoto K, Kamano T: Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry. Rinsho Byori. 2006 Feb;54(2):103-10. [PubMed:16548228 ]
- Smith JL, Lewindon PJ, Hoskins AC, Pereira TN, Setchell KD, O'Connell NC, Shepherd RW, Ramm GA: Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis. Hepatology. 2004 Jun;39(6):1673-82. [PubMed:15185309 ]
- Nobilis M, Pour M, Kunes J, Kopecky J, Kvetina J, Svoboda Z, Sladkova K, Vortel J: High-performance liquid chromatographic determination of ursodeoxycholic acid after solid phase extraction of blood serum and detection-oriented derivatization. J Pharm Biomed Anal. 2001 Mar;24(5-6):937-46. [PubMed:11248487 ]
- Lupton JR, Steinbach G, Chang WC, O'Brien BC, Wiese S, Stoltzfus CL, Glober GA, Wargovich MJ, McPherson RS, Winn RJ: Calcium supplementation modifies the relative amounts of bile acids in bile and affects key aspects of human colon physiology. J Nutr. 1996 May;126(5):1421-8. [PubMed:8618139 ]
- Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R: Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hepatology. 1995 Jul;22(1):82-7. [PubMed:7601437 ]
- Reyes H, Sjovall J: Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med. 2000 Mar;32(2):94-106. [PubMed:10766400 ]
- Morton DH, Salen G, Batta AK, Shefer S, Tint GS, Belchis D, Shneider B, Puffenberger E, Bull L, Knisely AS: Abnormal hepatic sinusoidal bile acid transport in an Amish kindred is not linked to FIC1 and is improved by ursodiol. Gastroenterology. 2000 Jul;119(1):188-95. [PubMed:10889168 ]
- Gatzen M, Pausch J: [Treatment of cholestatic liver diseases]. Med Klin (Munich). 2002 Mar 15;97(3):152-9. [PubMed:11957790 ]
- Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH: Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease. J Gastroenterol Hepatol. 1996 Mar;11(3):208-15. [PubMed:8742915 ]
|
---|